FTRE (Fortrea Holdings) Beta: 2.0970 (As of Jun. 29, 2026)


FTRE Fortrea Holdings Inc FTRE
66 GF Score
Price $17.64
GF Value $18.26
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Beta?

Fortrea Holdings FTRE -0.06% 66 Beta is 2.0970 as of Jun. 29, 2026. GuruFocus rates FTRE with a GF Score™ of 66/100 and a GF Value™ of $18.26 (Fairly Valued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Fortrea Holdings's Beta is 2.0970.


Fortrea Holdings  (NAS:FTRE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Fortrea Holdings Beta Related Terms


Fortrea Holdings Beta Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Beta Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FTRE vs SEPN, MLTX, URGN: Beta Comparison

For the Biotechnology subindustry, Fortrea Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortrea Holdings Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's Beta falls into.


FTRE
66GF Score
Fortrea Holdings Inc FTRE
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.0970 mean?
Fortrea Holdings (FTRE) has a Beta of 2.0970 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fortrea Holdings and its competitors.
Is Fortrea Holdings' Beta too high?
Fortrea Holdings' current Beta is 2.0970. Overall, Fortrea Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Beta compare to SEPN and MLTX?
Fortrea Holdings' Beta of 2.0970 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fortrea Holdings and its competitors. Fortrea Holdings's current Beta is 2.0970. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Based on GuruFocus' analysis, Fortrea Holdings (FTRE) is currently considered Fairly Valued. The stock's GF Value™ is $18.26, compared to a current price of $17.64 — trading 3.4% below its estimated fair value. The current Beta is 2.0970. Fortrea Holdings' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Fortrea Holdings (FTRE), the current Beta is 2.0970 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (FTRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of $17.64 is trading 3.4% below its estimated GF Value™ of $18.26. GuruFocus considers Fortrea Holdings to be Fairly Valued.

Key valuation signals for FTRE:

  • Beta: 2.0970
  • GF Value™: $18.26 vs. price of $17.64 (3.4% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the FTRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fortrea Holdings Business Description

Other Exchanges K67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
66GF Score

Get the complete analysis for FTRE

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.64
Price
$18.26
GF Value